Marc Trossaërt

2.5k total citations
77 papers, 1.5k citations indexed

About

Marc Trossaërt is a scholar working on Hematology, Surgery and Genetics. According to data from OpenAlex, Marc Trossaërt has authored 77 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Hematology, 18 papers in Surgery and 17 papers in Genetics. Recurrent topics in Marc Trossaërt's work include Hemophilia Treatment and Research (40 papers), Platelet Disorders and Treatments (29 papers) and Blood Coagulation and Thrombosis Mechanisms (26 papers). Marc Trossaërt is often cited by papers focused on Hemophilia Treatment and Research (40 papers), Platelet Disorders and Treatments (29 papers) and Blood Coagulation and Thrombosis Mechanisms (26 papers). Marc Trossaërt collaborates with scholars based in France, United States and United Kingdom. Marc Trossaërt's co-authors include Édith Fressinaud, Catherine Ternisien, Marianne Sigaud, Marc Fouassier, Catherine Boyer‐Neumann, Isabelle Martin, Agnès Veyradier, Dominique Meyer, E Fressinaud and P Commin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Pediatrics.

In The Last Decade

Marc Trossaërt

69 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Trossaërt France 20 1.0k 455 273 262 251 77 1.5k
R. Luddington United Kingdom 17 907 0.9× 326 0.7× 500 1.8× 620 2.4× 152 0.6× 26 1.7k
Meera Chitlur United States 22 938 0.9× 177 0.4× 119 0.4× 169 0.6× 188 0.7× 77 1.4k
Sean Platton United Kingdom 18 571 0.6× 412 0.9× 150 0.5× 227 0.9× 72 0.3× 38 1.8k
Pierre Toulon France 20 511 0.5× 219 0.5× 177 0.6× 352 1.3× 85 0.3× 85 1.2k
Joost J. van Veen United Kingdom 19 532 0.5× 240 0.5× 442 1.6× 463 1.8× 131 0.5× 34 1.2k
Martine Wolf France 14 490 0.5× 431 0.9× 152 0.6× 222 0.8× 145 0.6× 25 1.0k
René van Oerle Netherlands 17 431 0.4× 144 0.3× 236 0.9× 298 1.1× 107 0.4× 31 936
Philip M. Blatt United States 17 714 0.7× 185 0.4× 252 0.9× 167 0.6× 203 0.8× 38 1.3k
Helen Savoia Australia 17 564 0.5× 196 0.4× 141 0.5× 151 0.6× 139 0.6× 45 1.1k
Eli Cohen United States 17 387 0.4× 438 1.0× 497 1.8× 415 1.6× 35 0.1× 23 1.5k

Countries citing papers authored by Marc Trossaërt

Since Specialization
Citations

This map shows the geographic impact of Marc Trossaërt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Trossaërt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Trossaërt more than expected).

Fields of papers citing papers by Marc Trossaërt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Trossaërt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Trossaërt. The network helps show where Marc Trossaërt may publish in the future.

Co-authorship network of co-authors of Marc Trossaërt

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Trossaërt. A scholar is included among the top collaborators of Marc Trossaërt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Trossaërt. Marc Trossaërt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Susen, Sophie, Marc Trossaërt, Moshe Zilberstein, et al.. (2025). A phase 1, open-label study to assess the pharmacokinetics, safety, and tolerability of a single intravenous injection of efanesoctocog alfa in adults with type 2N or type 3 von Willebrand disease. Journal of Thrombosis and Haemostasis. 24(1). 79–87. 2 indexed citations
2.
Guillet, Benoît, Roseline d’Oiron, Marc Trossaërt, et al.. (2025). F8 gene variants influence the response to desmopressin in hemophilia A carriers. Blood. 146(16). 1991–2004.
3.
Trossaërt, Marc, et al.. (2024). Use of clinical biological tests of haemostasis to evaluate topical haemostatics. International Journal of Laboratory Hematology. 46(3). 531–537. 1 indexed citations
4.
Sigaud, Marianne, et al.. (2024). Bleeding management in type 3 von Willebrand disease with anti‐von Willebrand factor inhibitor: A literature review and case report. SHILAP Revista de lepidopterología. 5(5). 964–970. 3 indexed citations
5.
Desprez, Dominique, Laurent Sattler, Catherine Ternisien, et al.. (2024). Efficacy and safety of a recombinant von Willebrand factor treatment in acquired von Willebrand syndrome in case of bleeding and surgical procedures. Haemophilia. 30(6). 1341–1347. 1 indexed citations
6.
Beurrier, Philippe, et al.. (2023). Efficacy and safety of turoctocog alfa in patients with hemophilia A requiring surgical procedures: A multicentre retrospective study. Transfusion. 63(12). 2321–2327. 1 indexed citations
7.
Debord, Camille, Marion Eveillard, Marc Trossaërt, et al.. (2023). Prothrombin consumption as an indicator of hemorrhagic phenotype in mild platelet function disorders. European Journal Of Haematology. 111(5). 787–795.
8.
Rugeri, Lucia, Annie Harroche, S. Combe, et al.. (2022). POSTER PRESENTATIONS. Haemophilia. 28(S1). 25–126. 5 indexed citations
9.
Fouasson‐Chailloux, Alban, Fabien Leboeuf, Yves Maugars, et al.. (2022). Gait Alteration Due to Haemophilic Arthropathies in Patients with Moderate Haemophilia. International Journal of Environmental Research and Public Health. 19(12). 7527–7527. 3 indexed citations
10.
Wargny, Matthieu, Yohann Repessé, Benoît Guillet, et al.. (2022). rFVIII‐Fc in severe haemophilia A: The incentive switch in case of high risk of joint bleedings. European Journal of Clinical Investigation. 52(10). e13824–e13824.
11.
Kenet, Gili, Yeu‐Chin Chen, Gillian Lowe, et al.. (2021). Real-World Rates of Bleeding, Factor VIII Use, and Quality of Life in Individuals with Severe Haemophilia A Receiving Prophylaxis in a Prospective, Noninterventional Study. Journal of Clinical Medicine. 10(24). 5959–5959. 16 indexed citations
12.
Fouasson‐Chailloux, Alban, Yves Maugars, Marc Trossaërt, et al.. (2021). Isokinetic knee strength deficit in patients with moderate haemophilia. Haemophilia. 27(4). 634–640. 6 indexed citations
13.
Sigaud, Marianne, Catherine Ternisien, Marc Fouassier, et al.. (2021). Prostate interventions in patients with mild haemophilia: Safe and feasible. Haemophilia. 27(6). e659–e666. 3 indexed citations
14.
Desprez, Dominique, Claire Flaujac, Brigitte Pan‐Petesch, et al.. (2021). Efficacy and safety of a recombinant Von Willebrand Factor treatment in patients with inherited Von Willebrand Disease requiring surgical procedures. Haemophilia. 27(2). 270–276. 9 indexed citations
15.
Gillet, Benjamin, Benoît Guillet, Philippe Beurrier, et al.. (2020). Bleeding complications during pregnancy and delivery in haemophilia carriers and their neonates in Western France: An observational study. Haemophilia. 26(6). 1046–1055. 5 indexed citations
16.
17.
Rugeri, Lucia, Marc Fouassier, Anne Lienhart, et al.. (2020). Management of previously untreated patients with severe haemophilia A preferentially treated with recombinant factor VIII products: Two French centres' real‐life experience. Haemophilia. 26(6). e349–e352. 1 indexed citations
18.
Trossaërt, Marc, J. Graveleau, Marianne Sigaud, et al.. (2019). The factor VIII:C/VWF:Ag ratio as a useful tool to predict relapse in patients with acquired haemophilia A: A retrospective cohort study. Haemophilia. 25(3). 527–534. 6 indexed citations
19.
Fouasson‐Chailloux, Alban, Yves Maugars, Claire Vinatier, et al.. (2018). Clinical relevance of 3D gait analysis in patients with haemophilia. Haemophilia. 24(5). 703–710. 15 indexed citations
20.
Lande, Gilles, et al.. (1998). Do inherited prothrombotic factors have a role in myocardial infarction with normal coronary arteriogram?. Journal of Internal Medicine. 244(6). 543–544. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Luddington Breakdown of academic impact, for papers by Meera Chitlur Breakdown of academic impact, for papers by Sean Platton Breakdown of academic impact, for papers by Pierre Toulon Breakdown of academic impact, for papers by Joost J. van Veen Breakdown of academic impact, for papers by Martine Wolf Breakdown of academic impact, for papers by René van Oerle Breakdown of academic impact, for papers by Philip M. Blatt Breakdown of academic impact, for papers by Helen Savoia Breakdown of academic impact, for papers by Eli Cohen
Rankless by CCL
2026